Aker Biomarine ASA
OSE:AKBM
Aker Biomarine ASA
Free Cash Flow
Aker Biomarine ASA
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Aker Biomarine ASA
OSE:AKBM
|
Free Cash Flow
-$10.8m
|
CAGR 3-Years
49%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Orkla ASA
OSE:ORK
|
Free Cash Flow
kr4.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Leroy Seafood Group ASA
OSE:LSG
|
Free Cash Flow
kr379.4m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-9%
|
|
|
SalMar ASA
OSE:SALM
|
Free Cash Flow
kr2.9B
|
CAGR 3-Years
61%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
|
Austevoll Seafood ASA
OSE:AUSS
|
Free Cash Flow
kr623m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-2%
|
|
|
Mowi ASA
OSE:MOWI
|
Free Cash Flow
€542.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
8%
|
|
Aker Biomarine ASA
Glance View
Aker BioMarine AS operates as a biotech innovator and Antarctic krill-harvesting company which develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
See Also
What is Aker Biomarine ASA's Free Cash Flow?
Free Cash Flow
-10.8m
USD
Based on the financial report for Dec 31, 2024, Aker Biomarine ASA's Free Cash Flow amounts to -10.8m USD.
What is Aker Biomarine ASA's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
38%
Over the last year, the Free Cash Flow growth was -468%. The average annual Free Cash Flow growth rates for Aker Biomarine ASA have been 49% over the past three years , 38% over the past five years .
You don't have any saved screeners yet